Icon close

Close

People

Jill Keller Hengen concentrates her practice on high-stakes government and internal investigations, both domestic and global.  She also counsels clients on anticorruption and regulatory compliance matters, advises companies on complex regulatory, legal and policy issues, and represents corporate entities and individuals in congressional, white collar and civil enforcement matters. Jill also has expertise in matters requiring crisis management and government relations experience.

Jill’s investigative experience includes criminal and civil issues relating to pharmaceuticals; biotechnology and medical devices, Foreign Corrupt Practices Act Matters, accounting-related fraud, and problematic conduct by public company officers related to gender and race.

Jill has an extensive background in government affairs, in which she represented corporations, foreign governments and nongovernmental organizations before the legislative and executive branches and in congressional investigations. This experience enables Jill to take a multifaceted approach to investigations that spans the legal and policy arenas on diverse issues. She is equipped to see the broader political implications a client faces while under investigation, and is able to develop and implement strategies that take the potential political and media attention associated with investigations into account.

Full Bio

Credentials

J.D., Georgetown University Law Center

B.A. Government and History, Cornell University, Dean's List, Distinction

District of Columbia

Georgia

Maryland

Anti-Defamation League Glass Leadership Institute Participant – 2014-2015


Anti-Defamation League

Icon close

Close

Recognition

Anti-Defamation League Glass Leadership Institute Participant – 2014-2015


Anti-Defamation League

Matters

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical company related to potential transfer of value reporting violations.

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical and healthcare company in an internal investigation related to potential off-label promotion issues.

Counseled companies in enhancing and reviewing their corporate compliance programs pursuant to various industry ethics guidance, such as the PhRMA and AdvaMed Codes.

See more
Icon close

Close

Matters

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical company related to potential transfer of value reporting violations.

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical and healthcare company in an internal investigation related to potential off-label promotion issues.

Counseled companies in enhancing and reviewing their corporate compliance programs pursuant to various industry ethics guidance, such as the PhRMA and AdvaMed Codes.

Conducted an investigation into problematic conduct by a public company officer related to compliance with COVID-19 health protocols and issues related to diversity.

Represented the Independent Directors of a publicly traded company into problematic conduct by its former CEO related to gender issues.

Represented a global healthcare supply distributor in congressional inquiries related to the supply of personal protective equipment during the COVID-19 pandemic.

Represented the audit committee of a public biopharmaceutical company in an internal investigation and related government investigations into allegations of accounting fraud, whistleblower retaliation and potential Anti-Kickback Statute violations.

Conducted an international investigation and controls review on behalf of an international NGO in connection with allegations of diversion of humanitarian funds to a terrorist organization in the Middle East.

Represented a Fortune 500 pharmaceutical and healthcare company in connection with anti-corruption investigations by the DOJ, SEC, UK Serious Fraud Office, and other government authorities in the Middle East and Asia.

Advised a Fortune 500 life sciences company in connection with corporate governance and enhancements to its global compliance program, including compliance with U.S. trade and economic sanctions.

Represented a South Africa based company in SEC and DOJ investigations into potential violations of the FCPA and federal securities laws in connection with a government social services tender and related public disclosures.

Represented a public pharmaceutical company before Congress to address an anomaly in the patent law that i Representing a for-profit university in Congressional investigations.

Represented the CEO of a publicly traded education company under investigation by the SEC and DOJ for insider trading.

Secured federal funding for a non-profit organization that provides mentors to foster children.

Represented a for-profit university in Congressional investigations.

Matters

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical company related to potential transfer of value reporting violations.

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical and healthcare company in an internal investigation related to potential off-label promotion issues.

Counseled companies in enhancing and reviewing their corporate compliance programs pursuant to various industry ethics guidance, such as the PhRMA and AdvaMed Codes.

See more
Icon close

Close

Matters

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical company related to potential transfer of value reporting violations.

Conducted an internal investigation on behalf of a Fortune 500 pharmaceutical and healthcare company in an internal investigation related to potential off-label promotion issues.

Counseled companies in enhancing and reviewing their corporate compliance programs pursuant to various industry ethics guidance, such as the PhRMA and AdvaMed Codes.

Conducted an investigation into problematic conduct by a public company officer related to compliance with COVID-19 health protocols and issues related to diversity.

Represented the Independent Directors of a publicly traded company into problematic conduct by its former CEO related to gender issues.

Represented a global healthcare supply distributor in congressional inquiries related to the supply of personal protective equipment during the COVID-19 pandemic.

Represented the audit committee of a public biopharmaceutical company in an internal investigation and related government investigations into allegations of accounting fraud, whistleblower retaliation and potential Anti-Kickback Statute violations.

Conducted an international investigation and controls review on behalf of an international NGO in connection with allegations of diversion of humanitarian funds to a terrorist organization in the Middle East.

Represented a Fortune 500 pharmaceutical and healthcare company in connection with anti-corruption investigations by the DOJ, SEC, UK Serious Fraud Office, and other government authorities in the Middle East and Asia.

Advised a Fortune 500 life sciences company in connection with corporate governance and enhancements to its global compliance program, including compliance with U.S. trade and economic sanctions.

Represented a South Africa based company in SEC and DOJ investigations into potential violations of the FCPA and federal securities laws in connection with a government social services tender and related public disclosures.

Represented a public pharmaceutical company before Congress to address an anomaly in the patent law that i Representing a for-profit university in Congressional investigations.

Represented the CEO of a publicly traded education company under investigation by the SEC and DOJ for insider trading.

Secured federal funding for a non-profit organization that provides mentors to foster children.

Represented a for-profit university in Congressional investigations.

Credentials

J.D., Georgetown University Law Center

B.A. Government and History, Cornell University, Dean's List, Distinction

District of Columbia

Georgia

Maryland

Anti-Defamation League Glass Leadership Institute Participant – 2014-2015


Anti-Defamation League

Icon close

Close

Recognition

Anti-Defamation League Glass Leadership Institute Participant – 2014-2015


Anti-Defamation League